#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15080	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2022	736.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	913	C,T	848,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15080	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2022	736.8	0	HET	.	.	.	C451T	.	451	451	C	665	665	C	847	C,T	603,186	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15080	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2022	736.8	0	HET	.	.	.	C207T	.	207	207	C	421	421	C	880	C,T	652,165	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	0	.	n	.	0	T695C	SNP	695	695	T	957	957	C	829	C,T	780,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1900	1900	G	919	G,A	657,218	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2233	2233	C	891	C,T	811,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2307	2307	A	930	A	881	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2859	2859	C	809	C	766	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27724	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3468	795.3	0	HET	.	.	.	C2212T	.	2212	2212	C	2474	2474	C	858	C,T	614,184	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1874	folP	855	855	100.0	folP.l15.c17.ctg.1	1573	118.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1125	1127	AGC	205;201;201	A;G,A;C	197;192,1;191	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5086	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3594	141.2	1	SNP	p	S91F	1	.	.	271	273	TTC	688	690	TTC	159;159;161	T;T;C	149;147;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5086	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3594	141.2	1	SNP	p	G95N	0	.	.	283	285	GGC	700	702	GGC	166;167;168	G;G;C	152;152;155	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5086	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3594	141.2	1	SNP	p	D95G	1	.	.	283	285	GGC	700	702	GGC	166;167;168	G;G;C	152;152;155	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1642	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1404	116.4	1	SNP	p	G45D	0	.	.	133	135	GGC	516	518	GGC	204;202;201	G;G;C	193;195;187	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	808	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1038	77.1	0	.	n	.	0	A197.	DEL	197	197	A	578	578	A	216	A	204	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2750	204.5	1	SNP	p	D86N	0	.	.	256	258	GAC	513	515	GAC	239;240;241	G;A;C	220;215;224	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2750	204.5	1	SNP	p	R87I	0	.	.	259	261	CGT	516	518	CGT	243;244;243	C;G;T	226;224;221	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2750	204.5	1	SNP	p	S87R	1	.	.	259	261	CGT	516	518	CGT	243;244;243	C;G;T	226;224;221	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2750	204.5	1	SNP	p	R87W	0	.	.	259	261	CGT	516	518	CGT	243;244;243	C;G;T	226;224;221	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2750	204.5	1	SNP	p	S88P	0	.	.	262	264	TCC	519	521	TCC	246;246;247	T;C;C	227;229;230	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4088	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2641	154.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1552	1554	GGC	201;204;205	G;G;C	193;196;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1309	1311	GCC	198;195;197	G;C;C	187;180;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1312	1314	ATG	198;200;199	A;T;G	186;188;185	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1324	1326	ACC	204;203;203	A;C,A;C	191;190,1;193	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1324	1326	ACC	204;203;203	A;C,A;C	191;190,1;193	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1825	1827	ACC	192;195;194	A;C;C	166;178;182	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1879	1881	GCG	177;178;180	G;C;G	165;169;170	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1879	1881	GCG	177;178;180	G;C;G	165;169;170	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2002	2004	GGT	171;174;173	G;G;T	157;160;161	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2011	2013	AGC	159;161;159	A;G;C	148;146;146	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3886	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2490	155.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2029	2031	CCG	142;141;139	C,G;C,G;G	113,4;106,1;108	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5912	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3035	193.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1603	1605	CCG	222;218;218	C,G;C;G,T	200,1;200;198,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2508	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1617	152.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	518	518	C	206	C	183	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2956	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1723	170.6	1	SNP	p	G120K	1	.	.	358	360	AAG	715	717	AAG	255;254;254	A;A;G	234;240;237	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2956	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1723	170.6	1	SNP	p	A121N	1	.	.	361	363	AAC	718	720	AAC	255;251;252	A;A;C	239;240;239	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2956	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1723	170.6	1	SNP	p	N121D	0	.	.	361	363	AAC	718	720	AAC	255;251;252	A;A;C	239;240;239	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10978	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4948	220.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1408	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1183	118.3	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	274;277;276	A;T;G	261;262;262	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
